Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.
Saved in:
| Title: | Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease. |
|---|---|
| Authors: | Elmer LW; Department of Neurology, University of Toledo College of Medicine, 3120 Glendale Avenue, Toledo, OH, 43614, USA. Lawrence.Elmer@utoledo.edu., Juncos JL; Department of Neurology and Movement Disorders, Emory University School of Medicine, Atlanta, GA, USA., Singer C; Department of Neurology, University of Miami, Miami, FL, USA., Truong DD; The Parkinson's and Movement Disorder Institute, Fountain Valley, CA, USA., Criswell SR; Department of Neurology, Washington University, St. Louis, MO, USA., Parashos S; Struthers Parkinson's Center, Golden Valley, MN, USA., Felt L; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA., Johnson R; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA., Patni R; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA. |
| Source: | CNS drugs [CNS Drugs] 2018 Apr; Vol. 32 (4), pp. 399-400. |
| Publication Type: | Journal Article; Published Erratum |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-1934 |
|---|---|
| DOI: | 10.1007/s40263-018-0510-z |
